Stephen J. Carriere's most recent trade in Evelo Biosciences Inc was a trade of 354 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 19, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Evelo Biosciences Inc | Stephen J. Carriere | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2023 | 354 | 1,063 | - | - | Restricted Stock Units | |
Evelo Biosciences Inc | Stephen J. Carriere | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2023 | 354 | 354 (0%) | 0% | - | Common Stock | |
Evelo Biosciences Inc | Stephen J. Carriere | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 19 Jan 2023 | 151 | 203 (0%) | 0% | 1.1 | 160 | Common Stock |
Evelo Biosciences Inc | Stephen J. Carriere | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 6,250 | 6,250 | - | - | Stock Option (Right to Buy) | |
Evelo Biosciences Inc | Stephen J. Carriere | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 1,417 | 1,417 | - | - | Restricted Stock Units |